Literature DB >> 35173840

MiR-1179 represses cell proliferation, migration and invasion of hepatocellular carcinoma through suppression of NUAK2.

Dejun Wang1, Xue Song1, Nan Zhang1, Yesong Guo1.   

Abstract

OBJECTIVE: To investigate the function and mechanism of miR-1179 in the tumorigenesis of hepatocellular carcinoma (HCC).
METHODS: The levels of miR-1179 and NUAK2 in clinical tissues or cell lines were examined using quantitative Real-time PCR (qRT-PCR). Cell Counting Kit-8 (CCK-8), EdU assay, colony formation, wound healing, Transwell assays and flow cytometry assays were conducted to examine the impact of miR-1179 on HCC cells. The protein expression of NUAK2 was detected using Western blotting assay. Bioinformatics analysis and luciferase reporter assays were conducted to reveal the association of miR-1179 with NUAK2.
RESULTS: MiR-1179 expression was significantly downregulated in HCC specimens and cell lines compared to normal samples and cells. The miR-1179 overexpression inhibited HCC cell migration, invasion and proliferation through targeting NUAK2. Overexpression of NUAK2 can reverse the effect of miR-1179 on hepatocellular carcinoma cells.
CONCLUSION: miR-1179 suppresses HCC developmen through targeting NUAK2. Which can be used as a potent HCC diagnostic marker. AJTR
Copyright © 2022.

Entities:  

Keywords:  NUAK2; hepatocellular carcinoma; miR-1179; microRNAs

Year:  2022        PMID: 35173840      PMCID: PMC8829634     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  47 in total

1.  Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma.

Authors:  Y J Chen; S H Yeh; J T Chen; C C Wu; M T Hsu; S F Tsai; P J Chen; C H Lin
Journal:  Gastroenterology       Date:  2000-08       Impact factor: 22.682

2.  Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance.

Authors:  Andreas Karakatsanis; Ioannis Papaconstantinou; Maria Gazouli; Anna Lyberopoulou; George Polymeneas; Dionysios Voros
Journal:  Mol Carcinog       Date:  2011-12-27       Impact factor: 4.784

Review 3.  Taking the stress out of melanoma.

Authors:  Matthew J Martin; David Carling; Richard Marais
Journal:  Cancer Cell       Date:  2009-03-03       Impact factor: 31.743

4.  Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre.

Authors:  Christoph Herold; Thomas Reck; Peter Fischler; Rudolf Ott; Martin Radespiel-Troeger; Marion Ganslmayer; Werner Hohenberger; Eckhart G Hahn; Detlef Schuppan
Journal:  Liver       Date:  2002-02

5.  MicroRNA expression profiles of circulating microvesicles in hepatocellular carcinoma.

Authors:  Liping Sun; Jingqiong Hu; Wei Xiong; Xiaomei Chen; Huiyu Li; Shenghua Jie
Journal:  Acta Gastroenterol Belg       Date:  2013-12       Impact factor: 1.316

6.  MiR-1179 inhibits the proliferation of gastric cancer cells by targeting HMGB1.

Authors:  Yongsheng Li; Ce Qin
Journal:  Hum Cell       Date:  2019-03-22       Impact factor: 4.174

7.  Local microRNA delivery targets Palladin and prevents metastatic breast cancer.

Authors:  Avital Gilam; João Conde; Daphna Weissglas-Volkov; Nuria Oliva; Eitan Friedman; Natalie Artzi; Noam Shomron
Journal:  Nat Commun       Date:  2016-09-19       Impact factor: 14.919

8.  Transforming growth factor β (TGFβ) induces NUAK kinase expression to fine-tune its signaling output.

Authors:  Constantinos Kolliopoulos; Erna Raja; Masoud Razmara; Paraskevi Heldin; Carl-Henrik Heldin; Aristidis Moustakas; Lars P van der Heide
Journal:  J Biol Chem       Date:  2019-01-08       Impact factor: 5.157

9.  Diagnostic Value of the Combination of Golgi Protein 73 and Alpha-Fetoprotein in Hepatocellular Carcinoma: A Meta-Analysis.

Authors:  Meiyu Dai; Xiaoli Chen; Xuexiang Liu; Zheng Peng; Jie Meng; Shengming Dai
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

10.  Circular RNA circFOXM1 Plays a Role in Papillary Thyroid Carcinoma by Sponging miR-1179 and Regulating HMGB1 Expression.

Authors:  Mao Ye; Haitao Hou; Minghai Shen; Shu Dong; Tao Zhang
Journal:  Mol Ther Nucleic Acids       Date:  2019-12-20       Impact factor: 8.886

View more
  1 in total

1.  BMI1 governs the maintenance of mouse GC-2 cells through epigenetic repression of Foxl1 transcription.

Authors:  Bo Zheng; Juanjuan Liu; Xiaodan Shi; Jinfu Xu; Ke Zhang; Hui Zhou; Tiantian Wu; Xiaoyan Huang; Cong Shen; Yuting Liang; Dan Zhao; Yueshuai Guo
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.